Effect of Gomutra haritaki on Diabetes mellitus type 2

A clinical study to evaluate the efficacy of Gomutra haritaki yog in the management of prameha(Madhumeha)W.S.R. Diabete mellitus type 2 - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/11/059441

Enrollment

100

Registered

2023-11-02

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. The patients having clinical sign & symptoms of the Prameha (Madhumeh) & willing for trial. 2. The patients who ages in between 25 – 70 years will be selected 3.international diagnosis criteria for diabetes (WHO) (A) Patient having F.B.S. level >125 mg/dl (B) P.P.B.S. level >180 mg/dl to 4. Either sex of different socio-economic groups.

Exclusion criteria

Exclusion criteria: 1. IDDM patients 2. Gestational diabetes. 3. Diabetes Mellitus produced due to other illnesses like Acromegaly, Cushing’s syndrome, pancreatic disorders etc. 4. Acute complications Diabetic Keto-acidosis & hyperglycemic hyperosmolar coma. 5. Pregnant & Lactating Mother. 6. History of severe unstable angina, MI, CVA, Renal failure

Design outcomes

Primary

Measure	Time frame
Symptoms like Polyurea, Turbidity, burning sensation in palm and sole, polydipsia, fatigue, general weakness, polyphagia, sugar in the urine, and cramps will be analyzed Timepoint: 3 months	—

Secondary

Measure	Time frame
fasting blood sugar & post prandial blood sugar will be analyzedTimepoint: 1 month & 2 months	—

Countries

India

Contacts

Public ContactDr Brahmanand sharma

Dr.Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur

bkmudgal9@gmail.com7976964483

Outcome results